TickerFactsScreenerDevelopers

10x Genomics, Inc. (TXG) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$10.70M2018: -$76.41M2019: $34.63M2020: -$217.90M2021: -$21.37M2022: -$33.61M2023: -$15.20M2024: $6.66M2025: $136.05M$136.05M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$136.05M+1941.6%
2024$6.66M+143.9%
2023-$15.20M+54.8%
2022-$33.61M-57.2%
2021-$21.37M+90.2%
2020-$217.90M-729.3%
2019$34.63M+145.3%
2018-$76.41M-614.2%
2017-$10.70M—